Colorectal adenocarcinoma

C3_COLORECTAL_ADENO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cancer registry: Topography ICD-O-3 — C1[8-9]\|C20 Cancer registry: Morphology ICD-O-3 — 8140 Cancer registry: Behaviour codes — 3 1 out of 7 registries used, show all original rules.	8123
4. Check minimum number of events None	8123
5. Include endpoints None	8123
6. Filter based on genotype QC (FinnGen only)	8123

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF9

NAME	C3_COLORECTAL_ADENO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C1[8-9]\|C20
CANC_TOPO_EXCL
CANC_MORPH	8140
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Colorectal adenocarcinoma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8123	3288	4835
Unadjusted period prevalence (%)	1.72	1.12	2.13
Median age at first event (years)	69.01	67.93	69.74

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7551: Matched controls
75503

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

16.5

323.0

780

524

A04AA02

ATC

granisetron; systemic, transdermal

11.9

323.0

1781

1905

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

323.0

3096

12968

JN4BD

NOMESCO Finland

Extensive body CT

7.7

323.0

2656

4976

JFB30

NOMESCO Finland

Right hemicolectomy

45.1

323.0

941

237

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

213.9

323.0

610

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

170.3

323.0

479

WF001

NOMESCO Finland

Preoperative radiotherapy

104.4

323.0

778

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

162.7

323.0

342

JG1BG

NOMESCO Finland

MRI of rectum

127.6

323.0

556

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

309.0

323.0

407

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

378.0

323.0

363

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

11.8

323.0

1126

1100

L01BC06

ATC

capecitabine; oral

88.0

323.0

3004

564

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

93.3

323.0

609

A03FA01

ATC

metoclopramide; systemic, rectal

6.6

323.0

3609

9186

B01AB05

ATC

enoxaparin; parenteral

4.2

323.0

4084

16445

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

133.8

323.0

834

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

109.6

323.0

463

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

140.4

323.0

523

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

10.7

323.0

1244

1363

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

7369.4

323.0

2887

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

4362.3

323.0

423

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

152.0

323.0

550

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

334.7

323.0

348

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

312.9

323.0

2922

152

UJF32

NOMESCO Finland

Coloscopy

11.0

323.0

5251

13000

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.0

323.0

1111

1587

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.7

323.0

3108

15479

WZC30

NOMESCO Finland

Teaching

4.5

323.0

1983

5550

JN4AD

NOMESCO Finland

Body CT examination

5.8

323.0

1578

3303

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

100.3

323.0

634

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

236.8

323.0

1129

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

323.0

347

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

19.3

323.0

986

584

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

345.3

323.0

1563

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

162.0

323.0

1609

126

WX302

NOMESCO Finland

Thoracal epidural anesthesy

17.1

323.0

1948

1505

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4213.1

323.0

1427

TJF80

NOMESCO Finland

Ostomy education

36.6

323.0

513

150

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

12.4

323.0

2604

3067

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

79.2

323.0

680

JG1CG

NOMESCO Finland

Extensive MRI of rectum

85.1

323.0

433

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

21.3

323.0

683

350

Z93.3

ICD-10 Finland

Colostomy status

56.1

323.0

518

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

18.5

323.0

802

482

130

Kela drug reimbursment

Malignant tumour

21.5

323.0

3812

3419

H02AB02

ATC

dexamethasone; systemic

6.3

323.0

1986

4049

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

2062.6

323.0

543

D75

ICPC

Malignant neoplasm colon/rectum

111.5

323.0

615

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

323.0

683

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

163.2

323.0

790

C20

ICD-10 Finland

Malignant neoplasm of rectum

193.3

323.0

718

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

14.6

323.0

586

431

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

8407.0

323.0

768

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

237.4

323.0

447

JFF23

NOMESCO Finland

Transversostomy

62.3

323.0

799

143

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

68.0

323.0

911

152

TPH07

NOMESCO Finland

Cathetrisation of artery

4.3

323.0

1675

4701

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

9.0

323.0

1555

2124

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

10.2

323.0

769

830

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

27.1

318.5

447

175

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

7.4

306.6

780

1158

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

8.3

301.4

709

932

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

6.6

286.1

794

1328

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.3

284.0

944

1975

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

6.9

278.2

739

1162

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

139.0

275.7

294

JFB46

NOMESCO Finland

Resection of sigmoid colon

17.0

271.3

444

277

UJG02

NOMESCO Finland

Proctoscopy

10.5

270.6

553

566

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

100.1

262.2

289

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

17.9

260.9

418

246

JN4CD

NOMESCO Finland

Very extensive body CT

5.8

259.8

791

1484

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

129.2

255.2

274

B01AB10

ATC

tinzaparin; parenteral

4.3

247.9

1019

2642

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

82.2

245.4

277

JFB43

NOMESCO Finland

Left hemicolectomy

29.9

239.7

327

114

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

116.6

238.8

259

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

52.1

236.5

286

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

168.0

232.3

244

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

11.7

225.7

433

389

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.4

225.4

569

824

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

65.3

222.3

259

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.3

220.2

1303

4547

JFF10

NOMESCO Finland

Loop enterostomy

43.5

218.2

273

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

127.0

217.6

234

WX402

NOMESCO Finland

General anaesthesia

2.9

214.6

1529

6051

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

108.8

212.4

232

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

90.2

211.6

236

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

107.8

210.4

230

WX600

NOMESCO Finland

Single shot through catheter

17.5

207.1

334

199

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

9.3

204.6

445

506

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

211.6

199.3

206

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

98.5

199.3

220

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

15.7

197.2

332

221

L01BC59

ATC

trifluridine, combinations; systemic

285.6

190.9

194

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.4

188.9

609

1208

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

280.9

187.8

191

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

100.8

187.1

206

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

35.5

186.7

244

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

92.5

186.2

207

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

134.8

184.2

197

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

184.1

176

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

274.6

183.6

187

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

271.5

181.6

185

Z51.5

ICD-10 Finland

Palliative care

3.6

180.7

920

2831

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

4.7

178.1

660

1522

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

1807.5

174.5

169

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

127.1

173.0

186

369

Kela drug reimbursment

Regorafenib

182.2

170.5

178

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

6.0

162.6

473

825

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

161.2

770

2238

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

125.7

159.8

172

176

Kela drug reimbursment

Regorafenib

124.9

158.8

171

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

116.6

157.7

171

XX3DW

NOMESCO Finland

Time consuming IT work

2.8

157.6

1123

4361

N02AA05

ATC

oxycodone; systemic

2.4

156.4

1648

7972

ZX120

NOMESCO Finland

Intravenous

2.9

156.3

1065

4017

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

167.5

156.1

164

A04AA01

ATC

ondansetron; systemic, rectal

3.6

152.6

763

2298

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4.3

151.9

605

1491

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

148.7

906

3163

JAH00

NOMESCO Finland

Laparotomy

5.5

148.0

462

877

1XC07

NOMESCO Finland

94.9

142.6

158

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

52.0

139.1

168

SPAT1125

SPAT

Stoma care and guidance

7.0

136.7

355

530

JJB10

NOMESCO Finland

Atypcal resection of liver

64.9

136.5

159

C18

ICD-10 Finland

Malignant neoplasm of colon

282.3

135.7

138

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

9.2

135.6

294

330

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

134.3

135.6

145

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

7.0

134.4

348

517

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

144.6

133.7

142

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.0

130.3

834

2997

N02BE01

ATC

paracetamol; systemic, rectal

2.1

125.8

6433

55263

ZX095

NOMESCO Finland

Combined chemoradiotherapy

16.5

125.1

205

127

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.7

122.5

582

1671

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

121.3

1856

10437

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.4

117.6

617

1916

JFB00

NOMESCO Finland

Partial resection of small intestine

6.8

116.3

307

468

Z93

ICD-10 Finland

Artificial opening status

37.7

115.2

148

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

86.8

114.4

128

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

85.5

112.4

126

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

111.7

107

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

111.6

882

3594

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

11.6

110.6

211

186

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

18.8

105.1

164

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.2

104.7

427

1068

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

24.1

103.5

149

Z43.3

ICD-10 Finland

Attention to colostomy

60.4

101.2

119

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

100.8

965

4350

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

210.8

100.7

104

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.8

100.1

457

1264

L01XE21

ATC

[U] regorafenib; oral

120.5

99.2

107

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

100.5

99.2

109

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

99.1

1104

5356

K56.7

ICD-10 Finland

Ileus, unspecified

5.8

97.9

291

518

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

13.7

95.7

169

126

E0000UV

ATC

1.7

94.0

2763

19073

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.9

94.0

274

476

A04AD12

ATC

aprepitant; systemic

6.1

93.8

266

446

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

55.8

92.4

110

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.9

92.4

616

2252

JF2AB

NOMESCO Finland

Colongraphy with X-ray

33.6

88.2

116

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.2

86.8

345

841

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

94.2

84.1

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

827.3

83.7

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.3

82.5

327

795

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

9.1

81.6

177

199

JGB36

NOMESCO Finland

Wide excision of rectum

77.7

81.3

JFB50

NOMESCO Finland

Other resection of colon

27.7

81.1

112

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

30.7

81.1

109

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.5

80.9

408

1221

D99

ICPC

Disease digestive system other

8.2

80.3

185

230

A04AA55

ATC

palonosetron, combinations; systemic

4.7

79.7

282

612

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.9

77.8

336

883

SPAT1262

SPAT

Handing over of treatment supplies

1.8

77.6

1591

9706

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

77.2

291

673

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.1

77.2

179

225

WW500

NOMESCO Finland

Blood transfusion

3.2

76.5

433

1411

JAH01

NOMESCO Finland

Laparoscopy

3.6

76.5

369

1065

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

36.7

76.1

Z31.5

ICD-10 Finland

Genetic counselling

4.1

76.0

317

807

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

12.4

76.0

140

115

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

4.9

75.2

257

537

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.6

73.7

573

2289

WX704

NOMESCO Finland

Intubation

2.5

73.1

612

2549

B01AB04

ATC

dalteparin; parenteral

2.7

72.1

532

2058

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

81.9

72.1

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

31.3

71.9

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

5.0

71.7

239

486

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.2

70.7

281

684

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

30.0

70.4

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

109.6

69.9

Z43.2

ICD-10 Finland

Attention to ileostomy

41.8

69.5

D18

ICPC

Change in faeces/bowel movements

4.3

69.2

267

632

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.3

68.1

218

424

V03AF03

ATC

calcium folinate; systemic

28.5

68.0

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

26.4

67.4

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

9.2

67.2

144

159

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

11.2

66.8

129

117

Z93.2

ICD-10 Finland

Ileostomy status

18.6

66.2

103

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

174.0

66.1

JFB40

NOMESCO Finland

Resection of transverse colon

28.4

65.8

R4110

NOMESCO Finland

Physiotherapy

1.6

65.6

1986

13494

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

29.0

65.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

65.4

1400

8597

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

74.8

65.2

JJB71

NOMESCO Finland

Laparoscopic resection of liver

74.8

65.2

ZXC96

NOMESCO Finland

Robot assisted procedure

3.5

64.4

317

929

A02BC02

ATC

pantoprazole; systemic

1.5

64.4

4685

39124

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

221.8

64.2

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

80.8

64.0

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

100.9

63.9

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.4

63.9

242

563

K92.1

ICD-10 Finland

Melaena

2.5

63.6

552

2337

L01BC53

ATC

tegafur, combinations; systemic

40.4

63.5

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

5.5

63.4

195

362

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

5.4

62.2

194

366

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

9.8

60.6

125

129

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

310.0

60.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

60.4

3389

26565

UJF34

NOMESCO Finland

Left colonoscopy

8.5

60.3

135

161

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

58.9

574

2577

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

127.0

58.9

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

16.2

58.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

58.6

1008

5731

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

57.9

352

1204

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

57.7

466

1896

JJB30

NOMESCO Finland

Excision of two segments of liver

61.4

57.4

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

10.5

57.3

114

110

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

294.1

57.3

6434

FHL

Anterior resection

29.9

57.2

ZX090

NOMESCO Finland

Other technic of radiotherapy

3.2

57.0

316

1013

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.3

56.6

140

195

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.1

56.5

228

564

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

46.4

56.4

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

40.4

54.1

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

116.9

53.8

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

6.1

53.7

150

248

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

68.2

53.2

JKA20

NOMESCO Finland

Cholecystectomy

3.0

53.1

318

1077

JFF24

NOMESCO Finland

Laparoscopic transversostomy

85.0

52.9

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

521.5

52.5

A79

ICPC

Malignancy NOS

4.6

52.2

188

416

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

52.1

671

3409

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.3

51.9

163

311

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

138.4

51.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

51.6

2240

16425

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

51.4

262

789

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.6

50.8

238

671

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

50.2

183

410

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

34.5

50.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

49.8

1287

8277

6404

FHL

Hemicolectomy on the right

23.5

48.8

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.5

48.6

238

695

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

246.5

48.1

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

4.1

48.0

195

486

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

47.9

294

1011

JFF26

NOMESCO Finland

Sigmoidostomy

25.0

47.5

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

39.7

46.9

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.4

46.8

174

398

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

60.4

46.3

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

18.2

46.1

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

45.9

8140/3-C18.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of colon

+∞

44.8

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.3

44.5

139

264

JFF13

NOMESCO Finland

Terminal enterostomy

19.9

44.3

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

82.3

43.9

1XC08

NOMESCO Finland

430.0

43.2

TPX15

NOMESCO Finland

Removal of vascular injection port

9.6

42.8

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.3

42.7

229

718

JFA42

NOMESCO Finland

Endoscopic injection in colon

11.0

42.1

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

216.1

41.9

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

41.7

423

1932

JJB20

NOMESCO Finland

Excision of single segment of liver

54.8

41.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

40.9

480

2338

S18

ICPC

Laceration/cut

1.4

40.8

2974

23891

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

40.6

355

1504

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

7.2

40.5

100

140

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

3.1

40.2

236

787

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

40.1

2088

15727

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

19.2

40.0

WX110

NOMESCO Finland

Local anesthesy

1.4

39.7

4188

35803

R4190

NOMESCO Finland

Nutritional therapy

3.0

39.2

232

779

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.2

38.9

124

242

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

38.8

332

1391

WF004

NOMESCO Finland

Palliative radiotherapy

3.2

38.4

214

691

1533A

ICD-9 Finland

Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]

+∞

37.5

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

11.4

37.0

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

24.9

37.0

6435

FHL

Abdominoperineal resection and colostomy

58.8

35.1

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.6

34.8

165

471

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

123.9

34.7

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

10.9

34.3

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.3

33.9

176

540

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

120.5

33.7

JFF30

NOMESCO Finland

Other colostomy

27.2

33.6

C18.52

ICD-10 Finland

Malignant tumor of flexura lienalis carcinoma of adenoma

+∞

33.3

D16

ICPC

Rectal bleeding

3.1

32.6

183

594

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

24.3

32.6

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

10.8

32.5

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

5.4

32.4

185

SPAT1153

SPAT

Removal of sutures

1.4

32.3

2268

17894

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.2

32.3

125

300

D77

ICPC

Malignant digestive neopl other/NOS

7.2

31.8

109

R50.9

ICD-10 Finland

Fever, unspecified

1.6

31.8

948

6265

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

31.7

1667

12474

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

31.6

907

5936

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

31.6

556

3156

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

9.2

31.4

WX002

NOMESCO Finland

Sedation and analgesia

1.5

31.3

1373

9905

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

53.1

31.3

K65.0

ICD-10 Finland

Acute peritonitis

3.9

31.0

129

331

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

70.1

30.9

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

85.4

30.7

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

7.9

30.7

1534A

ICD-9 Finland

Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]

160.6

30.7

C209

ICD-10 Finland

110.5

30.7

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

10.4

30.5

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

20.6

30.4

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.5

30.3

109

244

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

14.8

29.9

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

10.6

29.8

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

45.2

29.6

TJG20

NOMESCO Finland

Transanal irrigation

12.4

29.4

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

50.2

29.3

K56.0

ICD-10 Finland

Paralytic ileus

4.1

29.3

118

294

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

6.5

29.1

117

WX882

NOMESCO Finland

High dependency care

2.5

28.9

231

936

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

3.6

28.5

131

366

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

28.4

558

3278

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

6.1

28.3

129

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

17.7

28.3

ZX121

NOMESCO Finland

Central venous catheter

8.6

28.1

D01.0

ICD-10 Finland

Carcinoma in situ: Colon

77.9

27.7

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

42.6

27.7

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

10.9

27.7

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

5.6

27.4

146

B80

ICPC

Iron deficiency anaemia

3.2

27.3

148

470

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

14.4

27.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

27.3

550

3255

SPAT1131

SPAT

Colonoscopy

2.3

27.3

260

1153

R03AC02

ATC

salbutamol; inhalant

0.8

27.3

2237

27085

JFB20

NOMESCO Finland

Ileocaecal resection

6.5

27.1

110

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

31.9

26.8

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

13.6

26.7

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.8

26.6

JFC10

NOMESCO Finland

Ileotransversostomy

24.8

26.5

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

6.1

26.2

119

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

6.7

25.3

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

24.9

456

2616

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.0

24.7

247

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

250.9

24.7

N03AX16

ATC

pregabalin; oral

1.4

24.4

1478

11272

A06AH03

ATC

naloxegol; oral

3.7

24.2

109

301

P01AB01

ATC

metronidazole; oral, rectal

1.3

24.0

2269

18547

J01MA12

ATC

levofloxacin; systemic

1.4

24.0

1332

9995

1536A

ICD-9 Finland

Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]

+∞

24.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

23.9

526

3196

Z51.0

ICD-10 Finland

Radiotherapy session

3.3

23.8

124

384

L01EX05

ATC

regorafenib; oral

67.6

23.8

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

5.1

23.8

147

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.7

23.7

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.5

23.3

126

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

24.7

23.0

JAL30

NOMESCO Finland

Omentectomy

4.1

22.8

222

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

22.7

409

2335

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

9.8

22.4

R11

ICD-10 Finland

Nausea and vomiting

1.7

22.4

495

3007

L03AA02

ATC

filgrastim; parenteral

2.3

22.4

202

874

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.1

22.3

248

1182

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.4

22.0

110

331

JAD10

NOMESCO Finland

Repair of incisional hernia

4.2

21.9

202

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.4

21.7

108

324

LEC00

NOMESCO Finland

Partial excision of vagina

20.1

21.6

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

220.5

21.6

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

115.3

21.6

3AC01

NOMESCO Finland

3.6

21.0

260

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

12.9

20.6

L01BC04

ATC

carmofur; oral

16.9

20.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

20.3

859

11550

JEA00

NOMESCO Finland

Appendectomy

1.8

20.2

338

1882

KCD10

NOMESCO Finland

Partial cystectomy

14.4

19.8

A06AD11

ATC

lactulose; oral

1.4

19.7

1129

8491

JFH10

NOMESCO Finland

Total colectomy and ileostomy

8.6

19.5

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

24.6

19.5

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

12.6

19.3

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

26.1

19.1

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

19.0

626

4215

JJA20

NOMESCO Finland

Open biopsy of liver

7.1

19.0

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.0

18.6

110

375

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

23.7

18.6

WGA11

NOMESCO Finland

Planning of pain management

12.3

18.5

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.2

18.4

300

JFC20

NOMESCO Finland

Other enterocolostomy

19.3

18.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

18.1

226

1131

XQ902

NOMESCO Finland

Other photography

4.8

18.1

126

JN4DD

NOMESCO Finland

Scout CT scan of torso

9.1

17.8

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

66.7

17.7

JFA70

NOMESCO Finland

Suture of small intestine

6.6

17.6

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

9.8

17.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

17.5

253

1342

WF002

NOMESCO Finland

Radical radiotherapy

1.7

17.4

380

2304

Z71.8

ICD-10 Finland

Other specified counselling

1.3

17.4

1234

9599

GDB10

NOMESCO Finland

Wedge resection of lung

8.6

17.3

D28

ICPC

Limited function/disability (D)

5.7

17.3

WX892

NOMESCO Finland

Monitored bed care

1.6

17.1

513

3377

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

8.6

16.9

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.1

16.7

186

889

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.7

16.7

119

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.6

16.7

205

NET99

NOMESCO Finland

Other operation on pelvis

35.1

16.6

C18.82

ICD-10 Finland

Malignant overall tumor of colon carcinoma of adenoma

170.3

16.5

LAE10

NOMESCO Finland

Unilateral oophorectomy

7.9

16.5

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

16.4

155

688

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

16.4

302

1740

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.6

16.3

121

474

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.2

16.3

150

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

10.4

16.1

XX1AD

NOMESCO Finland

Other CT-examination

4.2

16.1

147

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.9

16.1

171

QX9VV

NOMESCO Finland

30.1

16.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

16.0

962

7275

JFH96

NOMESCO Finland

Other total colectomy

21.0

15.9

LCD00

NOMESCO Finland

Hysterectomy

1.9

15.9

221

1156

M25.5

ICD-10 Finland

Pain in joint

0.7

15.8

920

11834

JFW98

NOMESCO Finland

Other transluminal endoscopic operation on intestine

60.1

15.7

1XA03

NOMESCO Finland

60.1

15.7

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

5.2

15.7

1540A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]

+∞

15.6

N02AX02

ATC

tramadol; systemic, rectal

1.2

15.6

2778

24240

JJA43

NOMESCO Finland

Destruction of lesion of liver

26.3

15.6

15302

ICD-8 Finland

Malignant neoplasm of large intestine, except rectum, Cacci

85.2

15.6

D29

ICPC

Digestive symptom/complaint other

2.5

15.5

121

489

JHA00

NOMESCO Finland

Anal or perianal incision

3.3

15.3

241

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

7.2

15.2

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

6.4

15.1

R01AD09

ATC

mometasone; nasal

0.8

15.1

1664

19798

A28

ICPC

Limited function/disability NOS

1.3

15.0

1140

8938

L03AA13

ATC

pegfilgrastim; parenteral

1.9

15.0

215

1140

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.2

14.9

246

ZX080

NOMESCO Finland

Image guided radiotherapy

2.3

14.8

137

606

ZX100

NOMESCO Finland

Oral

2.5

14.6

115

469

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

14.4

1034

8030

NK6LA

NOMESCO Finland

Bone and joint kinetic X-ray examination

10.8

14.4

R19.4

ICD-10 Finland

Change in bowel habit

2.2

14.1

145

670

M01AH05

ATC

etoricoxib; oral

0.8

13.9

2635

29751

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

8.8

13.9

B82

ICPC

Anaemia other/unspecified

2.0

13.9

170

851

JFA68

NOMESCO Finland

Endoscopic insertion of prosthetic tube into colon

30.1

13.9

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

7.8

13.8

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

3.3

13.8

212

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

11.4

13.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

13.6

226

1261

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.9

13.6

C18.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of colon

75.2

13.6

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

14.7

13.5

K63.5

ICD-10 Finland

Polyp of colon

2.7

13.4

346

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

16.2

13.4

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.8

13.4

1229

14965

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

5.5

13.2

D50

ICD-10 Finland

Iron deficiency anaemia

2.5

13.2

100

400

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

13.8

13.2

6406

FHL

Other column resection

8.5

13.2

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

10.4

13.2

K61.1

ICD-10 Finland

Rectal abscess

6.3

13.2

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

5.6

13.1

UJF32

SPAT

2.5

13.1

104

425

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

4.4

13.0

105

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

10.0

12.9

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

12.9

627

4565

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.5

12.9

103

422

M01AC06

ATC

meloxicam; systemic, rectal

0.8

12.8

1583

18672

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.6

12.8

340

SPAT1255

SPAT

Intravenous administration of medicine

1.5

12.7

413

2773

R18

ICD-10 Finland

Ascites

2.2

12.5

124

567

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

2.9

12.5

250

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

12.5

860

6636

D07AA02

ATC

hydrocortisone; topical

1.4

12.5

680

5054

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

3.9

12.4

129

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.5

12.4

402

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

12.4

1094

13398

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

5.1

12.4

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

12.3

667

4952

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.7

12.3

528

7115

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

37.6

12.2

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.6

12.1

333

M01AE02

ATC

naproxen; oral, rectal

0.8

12.1

2585

28992

JFB96

NOMESCO Finland

Other partial excision of intestine

12.4

12.1

N32.1

ICD-10 Finland

Vesicointestinal fistula

5.2

12.0

RD211

NOMESCO Finland

1.7

12.0

246

1466

SPAT1078

SPAT

Removal of central venous or arterial cannula

8.1

12.0

Z93.4

ICD-10 Finland

Other artificial openings of gastrointestinal tract status

21.3

12.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

12.0

854

6620

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

46.7

11.9

J01MA02

ATC

ciprofloxacin; systemic

1.2

11.8

2612

23102

ZXC40

NOMESCO Finland

Use of ultrasound

3.4

11.8

166

UJH02

NOMESCO Finland

Anoscopy

1.7

11.8

230

1351

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

2.9

11.7

250

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

16.4

11.6

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

11.5

124

587

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

11.5

1332

15850

1531A

ICD-9 Finland

Malignant neoplasm of colon, Transverse colon[NEOPL MALIG COLI TRANSV,INVASIIVINEN KARSINOOMA]

+∞

11.5

15311

ICD-8 Finland

Malignant neoplasm of large intestine, except rectum, Transverse colon, including hepatic and splenic flexures

+∞

11.5

KBH20

NOMESCO Finland

Replantation of ureter

6.9

11.3

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

6.9

11.3

M02AA07

ATC

piroxicam; topical

0.8

11.3

1806

20817

M03BX02

ATC

tizanidine; oral

0.8

11.2

2756

30612

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.3

11.2

101

443

N05AX08

ATC

risperidone; systemic

0.6

11.2

217

3379

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.2

11.2

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.7

11.0

202

1168

M01AB05

ATC

diclofenac; systemic, rectal

0.8

11.0

3417

37258

ZX050

NOMESCO Finland

Stereotactic radiotherapy

3.0

11.0

213

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

3.5

10.9

145

N81.6

ICD-10 Finland

Rectocele

0.5

10.9

118

2118

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

4.9

10.9

D17

ICPC

Incontinence of bowel

2.9

10.9

228

M48.0

ICD-10 Finland

Spinal stenosis

0.7

10.8

500

6673

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

10.8

1159

13919

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

8.2

10.8

N06CA01

ATC

amitriptyline and psycholeptics; systemic

0.7

10.7

293

4264

KCH00

NOMESCO Finland

Suture of bladder

5.8

10.7

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

4.0

10.6

103

JGA58

NOMESCO Finland

Endoscopic insertion of prosthetic tube into rectum

60.1

10.6

JF2CG

NOMESCO Finland

Extensive MRI of colon

60.1

10.6

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

7.9

10.6

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

9.1

10.5

M03BC51

ATC

orphenadrine, combinations; systemic

0.8

10.3

985

11982

ZSJ00

NOMESCO Finland

Procedure related to previous procedure classified in chapter J

7.7

10.3

WX004

NOMESCO Finland

Patient-controlled sedation

4.0

10.3

101

Z93.8

ICD-10 Finland

Other artificial opening status

16.0

10.3

GDB20

NOMESCO Finland

Segmental resection of lung

12.0

10.3

JAQ10

NOMESCO Finland

Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity

32.5

10.3

JJA40

NOMESCO Finland

Excision of lesion of liver

32.5

10.3

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2024

6371

3.90

307.65

2.5

2.1

g/l

0.2

2.25

1957

5847

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3248

16384

2.64

307.65

3.1

2.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6073

6886

31.98

307.65

9.7

2.8

ug/l

33.1

20.7

1.30

5602

5555

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1781

2437

9.08

307.65

6.1

2.9

u/ml

1435.2

2703.4

0.48

1609

2051

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5187

30643

2.92

307.65

5.6

4.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

955

1432

7.42

307.65

5.5

2.8

u/ml

161.4

782.8

2.23

869

1308

(3024561) Albumin [Mass/volume] in Serum or Plasma

5185

30834

2.88

307.65

10.4

4.6

g/l

33.2

34.7

61.73

5000

28310

(3022145) Colonoscopy Study observation

3050

6759

6.62

307.65

1.5

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

4015

21507

2.71

307.65

3.4

2.6

—

(4035726)

1750

5869

3.53

307.65

1.3

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5700

35746

2.99

307.65

14.8

5.9

umol/l

11.6

12.1

2.29

5566

33794

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1818

7442

2.86

302.97

3.0

2.7

umol/l

9.0

9.3

0.25

1675

6472

(3032080) INR in Blood by Coagulation assay

4717

30907

2.25

269.50

9.5

11.0

inr

1.2

1.3

12.32

1245

8424

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3593

21433

2.21

254.68

2.8

2.6

u/l

55.5

59.2

4.00

3429

19640

(40768804) Tissue Pathology biopsy report

4070

25615

2.18

250.66

2.8

2.2

—

(3033658) Prothrombin time (PT) actual/Normal

3022

16926

2.25

249.05

5.4

4.0

87.9

84.7

9.25

2992

16491

(3037121) Protein [Mass/volume] in Urine

831

2377

3.78

248.28

6.3

2.7

g/l

0.2

0.3

10.96

643

918

(3023368) Bacteria identified in Blood by Culture

3502

21299

2.13

229.54

5.0

4.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1440

6076

2.66

219.85

2.4

u/l

35.0

46.7

0.77

1329

5150

(3013650) Neutrophils [#/volume] in Blood by Automated count

5216

37203

2.12

219.39

16.5

8.6

e9/l

3.9

4.3

29.37

4747

32142

(3014576) Chloride [Moles/volume] in Serum or Plasma

1872

9635

2.23

180.09

9.2

6.7

mmol/l

105.1

104.4

9.11

1841

9420

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6419

51415

2.18

175.03

16.1

7.5

u/l

91.9

80.3

31.24

6226

48043

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1929

10210

2.17

171.98

2.2

2.7

18.5

21.8

20.43

1693

8509

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2007

10858

2.13

168.64

2.2

2.6

g/l

2.4

2.3

25.68

1909

9932

(3022948) Iron [Moles/volume] in Serum or Plasma

2098

11679

2.07

162.52

2.3

2.6

umol/l

10.9

12.2

12.41

1984

10664

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

377

823

4.75

160.22

2.1

2.3

u/ml

254.7

679.2

0.55

371

810

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2914

18587

1.89

149.44

2.3

mg/l

4.0

3.1

36.57

2518

15654

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2291

13635

1.95

144.04

9.6

2.9

mmol/l

2.5

8.32

2146

11794

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3001

19737

1.83

136.50

4.7

3.2

u/l

37.5

36.0

0.16

2897

18528

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1151

5397

2.32

134.95

1.6

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5257

41010

1.80

131.37

6.0

4.9

mmol/l

6.9

1.66

5074

38574

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1961

11755

1.88

116.67

5.3

3.0

mmol/l

0.8

13.51

1874

10860

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

917

4190

2.34

113.03

8.8

9.5

—

(3003694) ABO and Rh group [Type] in Blood

2416

15617

1.78

111.38

1.4

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3361

23825

1.70

111.21

8.2

3.2

mmol/l

2.3

2.4

1.16

3063

20244

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

701

2866

2.58

110.03

2.6

2.8

u/ml

0.3

1.65

407

1639

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1365

7455

2.00

106.07

8.1

7.6

g/l

115.9

120.4

15.14

1327

7178

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4302

32836

1.66

105.06

7.2

6.1

mmol/l

1.2

18.03

3989

29393

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3512

25517

1.66

103.46

2.9

ug/l

138.3

162.9

2.75

3217

23004

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4629

36115

1.65

102.70

8.2

6.8

mmol/l

1.2

25.94

3926

30170

(3016502) Oxygen saturation in Arterial blood

1451

8225

1.93

100.65

7.8

7.1

96.7

95.3

15.11

1409

7888

(3003396) Base excess in Arterial blood by calculation

1546

9113

1.86

94.42

7.5

6.8

mmol/l

0.8

1.1

1.70

1255

7043

(3027801) Oxygen [Partial pressure] in Arterial blood

1543

9150

1.85

92.21

7.5

6.8

kpa

13.9

11.9

35.79

1486

8664

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1543

9155

1.85

92.02

7.5

6.8

kpa

5.1

2.85

1489

8684

(40758558) Short blood count panel - Blood

2420

16369

1.68

91.00

13.0

6.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1207

6684

1.95

88.77

6.1

6.6

mmol/l

1.3

1.4

1.74

1152

6417

(3002256) Pathology report gross observation

1456

8773

1.80

81.49

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1582

10057

1.71

72.45

2.2

2.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5282

44590

1.53

67.95

5.0

e6/l

1996.1

1811.9

0.06

734

(3020779) Urea [Moles/volume] in Serum or Plasma

1182

7046

1.79

67.42

5.4

6.8

mmol/l

9.6

11.1

8.84

1126

6648

(3002582) Erythrocytes [#/volume] in Urine

2942

22020

1.53

67.32

3.6

3.5

e6/l

80.2

107.9

0.63

2407

17140

(3014007) Fractional oxyhemoglobin in Arterial blood

896

4929

1.92

65.94

8.5

8.6

94.9

93.8

7.02

896

4906

(3000991) Gas panel - Venous blood

1069

6321

1.80

62.30

7.2

7.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

504

2327

2.24

59.37

1.3

—

(36304419) Bacteria [Presence] in Urine

2589

19326

1.50

57.76

3.5

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

2681

20189

1.49

57.13

3.5

3.4

e6/l

0.5

0.28

2161

15440

(3026782) Osmolality of Urine

2043

14616

1.53

55.33

3.1

2.9

mosm/kgh2o

539.9

552.6

1.94

1812

12381

(40768441) Liver Pathology biopsy report

158

408

3.93

53.82

1.1

1.3

—

(3039000) Anion gap in Blood

398

1741

2.35

53.17

8.1

6.8

mmol/l

11.1

11.3

0.96

364

1555

(3018572) Chloride [Moles/volume] in Blood

398

1741

2.35

53.17

8.1

6.8

mmol/l

106.3

104.9

8.15

364

1555

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

13.79

51.86

1.0

—

(3018095) Leukocytes [#/volume] in Urine

3134

24907

1.42

47.87

4.2

3.9

e6/l

139.4

111.2

0.97

2495

18266

(3025941) Bacteria identified in Stool by Culture

600

3214

1.94

47.23

1.3

—

(3047181) Lactate [Moles/volume] in Blood

481

2391

2.08

46.76

7.3

6.0

mmol/l

1.4

1.3

0.87

433

2108

(3000850) Epithelial cells [#/volume] in Urine

2104

15600

1.47

46.42

2.8

2.7

e6/l

5.2

4.5

1.28

1879

13618

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

716

4110

1.81

45.33

8.6

8.7

mmol/l

24.0

24.3

2.24

690

3786

(3006504) Eosinophils/100 leukocytes in Blood

3662

30105

1.39

45.03

4.7

5.9

2.7

2.9

3.82

3405

27718

(3019069) Monocytes/100 leukocytes in Blood

3676

30271

1.39

44.59

4.9

6.2

9.0

8.9

1.13

3421

27967

(3026008) Bacteria identified in Urine by Culture

2816

22221

1.41

43.65

3.4

—

(42870588) Differential panel, method unspecified - Blood

2876

22781

1.41

43.59

4.4

5.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

3724

30830

1.38

43.25

4.9

6.1

23.3

26.2

42.13

3439

28300

(3008152) Bicarbonate [Moles/volume] in Arterial blood

840

5117

1.72

43.19

8.2

6.9

mmol/l

24.5

0.22

799

4759

(3022096) Basophils/100 leukocytes in Blood

3565

29314

1.39

43.09

4.7

5.9

0.6

0.7

15.80

3310

27018

(3019060) Gas panel - Arterial blood

884

5465

1.69

43.03

6.0

4.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6810

62713

1.53

41.94

28.8

17.0

mg/l

37.2

26.6

95.67

6333

51227

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

605

3380

1.85

41.72

1.9

ug/l

2.0

2.4

0.39

544

2932

(3018010) Neutrophils/100 leukocytes in Blood

3639

30344

1.36

38.82

4.7

5.8

60.7

58.5

19.70

3387

27991

(3006315) Basophils [#/volume] in Blood

3827

32223

1.35

38.05

4.5

5.6

e9/l

0.0

10.89

3265

27425

(3027945) Reticulocytes/100 erythrocytes in Blood

1334

9356

1.51

37.72

2.0

2.4

1.8

0.43

1176

8156

(3037467) Urinalysis macro (dipstick) panel - Urine

5158

45549

1.36

37.13

5.5

4.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

578

3305

1.81

36.85

6.5

5.0

0.9

2.20

540

3098

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

582

3341

1.80

36.62

6.4

5.0

1.6

0.13

545

3129

(3001604) Monocytes [#/volume] in Blood

3794

32025

1.35

36.52

4.5

5.6

e9/l

0.6

0.40

3227

27222

(3018418) pH of Serum or Plasma

2673

21426

1.37

35.82

4.9

4.1

7.4

1.29

570

4078

(3019198) Lymphocytes [#/volume] in Blood

3863

32792

1.34

35.34

4.6

5.7

e9/l

1.7

1.9

1.99

3352

28355

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1356

9698

1.48

34.52

4.5

5.7

mmol/l

1.0

0.49

1261

8917

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1580

11640

1.44

34.45

3.3

3.2

e6/l

2.8

2.0

2.48

947

6565

(3013115) Eosinophils [#/volume] in Blood

3896

33228

1.33

33.98

4.6

5.8

e9/l

0.2

5.08

3375

28639

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4357

37833

1.33

33.19

3.8

3.2

u/l

70.5

54.9

10.89

4076

34292

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

297

1483

2.04

28.47

1.3

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1660

12715

1.38

28.23

1.8

1.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

184

762

2.45

27.83

1.1

g/l

1.6

0.96

174

677

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

337

1775

1.94

27.75

2.1

2.3

g/l

3.7

3.6

0.21

331

1681

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

626

4056

1.59

24.77

2.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

197

889

2.25

24.53

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1062

7703

1.44

24.39

4.9

3.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

192

870

2.24

23.68

1.3

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

987

7117

1.44

23.34

2.1

2.5

e9/l

69.8

68.3

0.56

764

5468

(3025468) Yersinia sp identified in Specimen by Organism specific culture

190

866

2.22

23.11

1.3

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1596

12505

1.34

22.85

3.2

3.0

e6/l

1.2

1.4

0.44

951

7379

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1502

11665

1.35

22.79

2.0

30.1

0.08

1467

11292

(40762365) Oxygen content in Arterial blood by calculation

140

4.24

22.71

3.3

2.8

ml/dl

13.7

14.9

3.02

129

(3024522) Salmonella sp identified in Specimen by Organism specific culture

191

879

2.20

22.70

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

189

868

2.21

22.58

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

189

871

2.20

22.39

1.3

1.4

—

(3019225) pH of Specimen

1026

7511

1.42

22.26

4.7

4.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

206

1001

2.09

21.32

5.8

6.4

mg/l

11.9

12.1

0.23

186

913

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

287

1582

1.84

20.59

2.1

2.4

221.5

204.3

2.60

274

1502

(3014765) Yersinia sp identified in Stool by Organism specific culture

309

1747

1.80

20.41

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

307

1733

1.80

20.39

1.1

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

988

7293

1.40

20.33

3.0

3.7

kpa

5.6

5.8

6.67

957

7067

(3002032) Base excess in Venous blood by calculation

982

7256

1.40

20.07

3.0

3.7

mmol/l

1.8

1.9

0.32

760

5861

(42529406) Shigella sp [Presence] in Stool by Culture

308

1755

1.78

19.83

1.1

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

302

1736

1.77

18.88

2.0

2.1

84.4

88.4

2.14

293

1635

(3019550) Sodium [Moles/volume] in Serum or Plasma

6943

66128

1.34

18.74

34.5

20.2

mmol/l

139.3

139.6

25.77

6829

64352

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

355

2154

1.68

18.27

1.8

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

6949

66247

1.34

18.21

34.6

20.4

mmol/l

4.0

20.59

6831

64372

(3051651) Icteric interference index of Serum or Plasma

106

417

2.56

18.02

5.3

3.6

—

(40761511) CBC panel - Blood by Automated count

6726

63862

1.31

17.87

29.2

16.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

389

2462

1.61

16.95

2.6

4.1

u/ml

62.4

80.4

0.75

378

2356

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

489

3270

1.53

16.75

1.9

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

644

4562

1.45

16.56

1.5

—

(40768797) Stomach Pathology biopsy report

1167

9115

1.33

16.54

1.2

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

257

1475

1.77

16.20

2.1

2.5

umol/l

32.1

34.2

0.72

215

1213

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1156

9063

1.32

15.91

3.0

4.1

u/l

250.1

248.4

0.11

1099

8484

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5689

60299

0.81

15.63

4.3

4.8

mmol/l

1.4

0.01

5045

54199

(3018405) Lactate [Moles/volume] in Arterial blood

435

2880

1.54

15.60

4.7

4.1

mmol/l

1.3

1.4

1.23

429

2828

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

708

9554

0.72

15.59

1.2

1.3

iu/ml

54.3

38.8

1.39

229

2917

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

515

3534

1.49

15.58

2.7

3.9

mmol/l

23.8

24.1

0.98

471

3151

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6221

58767

1.25

15.47

29.7

16.2

ml/min/173m2

76.0

73.6

18.40

5629

48792

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5751

60868

0.81

15.45

4.3

4.8

mmol/l

4.5

0.16

5148

55111

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

448

3000

1.52

15.25

1.9

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5592

59309

0.82

15.04

6.4

6.6

mmol/mol

41.3

40.9

2.12

5006

53821

(3013512) EKG study

2491

21585

1.22

14.60

4.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1036

8100

1.32

14.45

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

666

8971

0.72

14.43

1.2

u/ml

19.3

14.0

0.69

241

3161

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1392

16923

0.79

14.41

1.6

mmol/l

1.4

1.3

2.62

1142

13906

(3020891) Body temperature

465

3192

1.48

14.05

5.2

4.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

348

2249

1.57

13.92

1.2

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

817

6205

1.35

13.87

1.6

2.1

ug/g

270.6

159.5

7.16

632

4817

(3044889) 12 lead EKG panel

4986

46330

1.20

13.31

4.5

4.3

—

(3052851) Hemolysis interference index of Serum or Plasma

338

2205

1.56

12.99

4.9

3.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

247

1503

1.66

12.67

1.2

titre

59.3

112.8

2.49

123

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

730

5526

1.35

12.64

4.3

2.7

ml/min/173m2

61.6

60.9

0.18

323

2305

(3012501) Base excess in Blood by calculation

279

1760

1.61

12.40

4.5

4.4

mmol/l

2.7

0.04

200

1207

(3051611) Lipemic interference index of Serum or Plasma

148

784

1.90

12.19

4.7

3.4

—

(3010421) pH of Blood

311

2023

1.56

12.13

4.4

4.3

7.4

0.14

275

1723

(3022217) INR in Platelet poor plasma by Coagulation assay

1360

11240

1.25

12.08

23.9

29.6

inr

1.4

1.5

2.79

218

1495

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5970

62560

0.83

12.07

4.8

5.4

mmol/l

2.6

1.00

5303

56395

(3034770) Mitochondria Ab [Titer] in Serum

244

1500

1.65

12.05

1.2

titre

401.7

960.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6862

66038

1.25

11.66

19.2

11.1

u/l

24.5

25.5

4.40

6707

63112

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

638

4798

1.36

11.52

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1833

15709

1.22

11.48

1.8

nmol/l

1190.9

1163.2

0.56

1394

11649

(3021589) Normoblasts [#/volume] in Blood

3115

28044

1.18

11.22

15.4

10.3

e9/l

0.0

0.78

2545

22862

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

530

3894

1.39

11.07

1.5

1.6

g/l

1.7

1.5

4.18

455

3308

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5548

58351

0.84

10.76

3.9

4.3

mmol/l

1.3

1.96

4882

51929

(3024354) Oxygen [Partial pressure] in Venous blood

770

6012

1.31

10.74

2.7

3.1

kpa

4.6

4.5

0.43

740

5799

(3033799) Differential panel - Peritoneal fluid

227

2.61

10.67

1.8

1.9

—

(3036489) Thrombin time

331

2248

1.49

10.61

1.9

21.5

21.8

0.48

312

2004

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

157

2.94

10.42

1.8

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

5686

53957

1.18

10.09

31.1

18.4

37.1

38.8

27.01

3563

33717

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1695

14580

1.21

10.03

3.7

4.2

ng/l

475.4

481.3

0.01

1437

12483

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

380

2.17

9.83

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

380

2.17

9.83

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

106

542

1.97

9.78

1.2

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1350

11390

1.22

9.71

1.2

u/ml

1.4

1.9

1.14

336

2860

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1070

8826

1.24

9.52

1.7

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

776

6173

1.28

9.37

4.7

4.0

mmol/l

1.2

1.63

701

5347

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

103

531

1.95

9.30

1.3

1.4

—

(4281824)

118

644

1.84

8.98

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

591

7562

0.76

8.84

1.2

1.3

titre

484.6

499.2

0.07

130

1614

(1616796) Gas panel - Central venous blood

261

1756

1.50

8.82

3.8

—

(3002385) Erythrocyte distribution width [Ratio]

5239

49645

1.16

8.56

37.9

20.7

14.7

13.9

168.82

5173

48420

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4362

46402

0.87

8.53

3.4

3.9

pmol/l

15.0

15.1

0.21

3816

41227

(40761536) Microorganisms panel - Urine sediment

699

5566

1.28

8.37

4.5

4.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3119

28574

1.15

8.10

3.9

4.2

ng/l

41.7

79.3

1.62

2530

21934

(3026493) Urate [Moles/volume] in Serum or Plasma

1632

18599

0.85

8.05

2.7

2.9

umol/l

3412.6

5816.5

1.96

1402

15716

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1051

8804

1.22

8.03

1.7

1.8

—

(3024731) MCV [Entitic volume]

6993

67932

1.21

7.97

44.5

24.9

91.2

91.7

14.04

6905

66617

(3026361) Erythrocytes [#/volume] in Blood

6993

67936

1.21

7.94

44.7

25.0

e12/l

4.3

4.4

126.20

6849

65536

(3007461) Platelets [#/volume] in Blood

6991

67919

1.21

7.91

44.7

25.0

e9/l

248.8

240.0

19.49

6861

65783

(3035941) MCH [Entitic mass]

6992

67932

1.21

7.89

44.5

24.8

30.1

30.5

51.37

6902

66616

(3000963) Hemoglobin [Mass/volume] in Blood

6993

67948

1.21

7.85

45.0

25.1

g/l

126.7

133.8

246.82

6903

66649

(3043409) Potassium [Moles/volume] in Arterial blood

340

2460

1.40

7.85

5.2

4.3

mmol/l

3.8

3.9

7.31

322

2305

(3010813) Leukocytes [#/volume] in Blood

6992

67951

1.21

7.76

44.7

25.0

e9/l

6.9

0.08

6855

65553

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

240

3454

0.69

7.60

1.3

au/ml

70.9

57.4

0.31

146

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5929

61547

0.86

7.54

4.7

5.1

mmol/l

6.2

6.1

3.52

5251

54862

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

116

666

1.75

7.54

1.2

—

(1761868) Lipid panel - Serum or Plasma

1599

18152

0.85

7.42

3.0

3.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

274

3830

0.71

7.38

2.4

au/ml

40.7

24.6

0.50

125

(3043410) Blood group antigens tested for on Red Blood Cells

190

2.43

7.30

2.0

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2019

22412

0.87

6.85

2.1

2.2

u/l

238.9

216.7

0.47

1899

20834

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.39

6.40

2.3

2.1

62.0

66.3

0.23

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

267

1927

1.40

6.33

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

140

892

1.58

6.18

2.2

3.6

u/ml

18.7

36.8

3.99

135

864

(3027273) Bicarbonate [Moles/volume] in Venous blood

497

3957

1.27

6.01

3.2

3.5

mmol/l

24.4

25.2

4.27

477

3839

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

378

1.89

5.98

1.8

1.9

u/field

2.8

2.0

0.49

254

(40767503) Oxygen content in Capillary blood by calculation

237

1696

1.41

5.93

2.5

2.6

15.4

15.8

0.77

118

903

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3263

30397

1.12

5.93

2.1

pmol/l

88.1

93.3

8.48

1899

15902

(4010399)

377

4843

0.77

5.83

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

471

5854

0.79

5.58

1.5

1.6

—

(3008898) HLA-B27 [Presence]

1273

0.57

5.52

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

521

6391

0.80

5.49

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

109

1718

0.63

5.49

1.3

1.4

—

(1002224) Polysomnography panel

109

1716

0.63

5.46

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

186

2.21

5.36

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

221

1594

1.40

5.33

1.2

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

586

4823

1.23

5.32

2.7

3.4

g/l

122.1

127.7

7.08

567

4702

(3013707) Erythrocyte sedimentation rate by Westergren method

4992

47796

1.12

5.27

3.6

4.3

mm/h

17.7

14.1

31.35

4505

43620

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1276

0.58

5.19

1.1

1.2

mmol/l

3.9

0.03

1190

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

129

1927

0.66

5.08

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1450

12952

1.15

5.04

4.0

4.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

102

638

1.61

4.95

1.7

2.2

u/field

3.1

1.7

1.23

224

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1256

0.59

4.91

1.3

1.4

e6/l

265.8

1235.0

2.64

1023

(3023487) Leukocytes [#/volume] in Peritoneal fluid

254

1.97

4.90

1.5

2.2

e6/l

11921.3

4280.7

0.29

178

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1255

0.59

4.89

1.2

1.3

e6/l

10.4

24.1

0.98

965

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

175

2444

0.71

4.80

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

415

1.74

4.77

2.2

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

531

0.39

4.69

1.0

ng/l

34.9

43.8

0.77

345

(3005322) IgE [Units/volume] in Serum or Plasma

234

3107

0.75

4.66

1.2

1.3

u/ml

200.8

253.8

0.66

211

2832

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

529

0.40

4.65

1.0

ng/l

669.9

707.1

0.21

339

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5509

56928

0.90

4.64

4.2

4.7

mu/l

2.7

2.1

0.56

4828

50858

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

571

4758

1.22

4.63

3.3

3.7

mmol/l

1.9

0.01

414

3508

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

526

0.40

4.60

1.0

ng/l

246.4

328.7

2.39

346

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

226

2.00

4.58

1.5

2.0

e6/l

19412.9

20896.1

0.04

125

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

840

7256

1.18

4.56

2.8

3.0

ng/l

240.9

235.6

0.13

764

6666

(3028626) Oxygen [Partial pressure] in Capillary blood

237

1778

1.34

4.53

2.8

2.9

kpa

8.0

7.8

0.43

222

1630

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

118

781

1.52

4.52

2.8

3.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

228

1706

1.35

4.44

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

228

1706

1.35

4.44

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

304

2374

1.29

4.38

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

190

2.06

4.33

1.2

1.6

g/l

14.1

14.0

0.00

149

(3000494) Fungus identified in Specimen by Culture

866

7542

1.17

4.25

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

592

4993

1.20

4.25

3.3

3.7

kpa

5.1

5.2

1.42

548

4566

(3009343) pH of Capillary blood

585

4931

1.20

4.22

3.3

3.7

7.4

0.11

633

(3015171) Extractable nuclear Ab [Units/volume] in Serum

152

2120

0.71

4.19

1.2

u/ml

3.6

0.7

0.73

215

(21494755) Public health laboratory ask at order entry panel

189

2546

0.74

4.19

1.3

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

651

5546

1.19

4.18

3.1

4.0

0.2

0.1

0.85

246

1647

(3017181) Myelocytes/100 leukocytes in Blood

684

5855

1.18

4.16

3.2

4.0

1.1

1.0

0.50

265

1784

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

452

3724

1.23

4.13

2.3

2.7

1.2

0.51

446

3699

(3019977) pH of Arterial blood

472

1.64

4.12

2.9

2.3

7.4

1.23

180

(3030981) Hyaline casts [#/volume] in Urine by Automated count

495

4119

1.21

4.10

3.3

3.0

e6/l

0.3

0.44

488

4037

(3004809) Band form neutrophils/100 leukocytes in Blood

179

1308

1.38

4.09

2.4

3.6

2.4

1.6

1.49

141

993

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

442

3645

1.22

4.01

2.2

2.6

0.7

0.08

427

3488

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.93

4.00

2.4

2.0

17.0

13.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

492

0.43

3.97

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

197

1.98

3.95

1.7

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

371

1.70

3.94

1.4

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

371

1.70

3.94

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

371

1.70

3.94

1.4

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

1926

17750

1.11

3.91

4.5

estimate

0.0

0.53

677

5628

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

238

3066

0.77

3.87

1.8

1.9

—

(4094501)

125

1772

0.70

3.82

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

863

0.58

3.77

4.2

4.4

umol/l

338.0

346.9

0.18

730

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

230

1772

1.31

3.72

1.3

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

371

1.68

3.68

1.5

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

2.79

3.68

1.1

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

615

5277

1.18

3.66

3.0

3.8

0.7

0.26

179

1268

(3021901) Oxygen saturation in Capillary blood

201

1525

1.33

3.64

2.7

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

620

5330

1.18

3.61

1.3

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1936

17939

1.10

3.49

1.6

nmol/l

20.5

20.1

0.48

1647

15156

(3007164) IgA [Mass/volume] in Serum or Plasma

1134

10212

1.13

3.44

1.5

g/l

2.6

2.7

0.15

632

5879

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

101

1456

0.69

3.43

1.4

1.6

mg/l

3.2

3.7

0.29

1059

(3014148) Varicella zoster virus Ab [Titer] in Serum

418

0.43

3.38

1.2

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2579

24256

1.09

3.37

2.8

3.2

ng/l

1700.3

1765.0

0.26

2245

21055

(3017446) Testosterone [Moles/volume] in Serum or Plasma

412

4912

0.83

3.36

2.0

2.1

nmol/l

10.3

12.1

4.03

351

4238

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

174

1315

1.33

3.28

1.0

1.1

u/ml

5.3

8.8

0.35

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

295

1.70

3.18

1.5

2.1

—

(4034850)

165

2167

0.76

3.16

14.0

11.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

225

1777

1.27

3.08

2.3

2.2

g/l

122.2

127.1

2.04

167

1299

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

172

1311

1.32

3.08

1.3

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

126

1710

0.73

3.04

1.5

1.6

iu/ml

4.0

8.5

0.41

417

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

229

0.35

3.03

1.1

1.8

ug/l

24.7

174.6

—

209

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

217

1713

1.27

2.99

1.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

294

1.67

2.95

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

294

1.67

2.95

1.5

2.1

—

(3045424) Erythrocytes [Presence] in Urine

149

1121

1.34

2.93

1.8

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

168

2174

0.77

2.92

2.7

2.3

g/l

0.0

0.00

150

1974

(3026250) Tacrolimus [Mass/volume] in Blood

210

0.33

2.90

39.3

31.2

ug/l

6.3

7.3

—

186

(3025159) Blasts/100 leukocytes in Blood

593

5178

1.16

2.88

3.2

4.0

0.3

0.00

198

1388

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

136

1806

0.75

2.86

1.3

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

253

2046

1.24

2.86

1.4

ug/g

240.9

263.2

1.02

160

1254

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1512

13977

1.10

2.83

1.6

1.7

mg/l

2.0

1.4

4.34

1231

10936

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1577

16990

0.91

2.82

3.1

3.3

ug/l

0.8

0.30

1108

12156

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

376

1.57

2.81

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

376

1.57

2.81

1.3

1.4

—

(3000492) Spirometry study

455

5283

0.85

2.77

1.4

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

3378

32330

1.08

2.74

4.3

4.1

estimate

0.0

1.84

751

5768

(3041096) Erythrocytes [Presence] in Urine by Automated

1759

16403

1.09

2.72

4.4

3.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

186

1462

1.28

2.69

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

122

1626

0.75

2.65

1.3

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

227

1.72

2.65

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.33

2.64

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

105

1427

0.73

2.61

1.6

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

580

5099

1.15

2.59

1.3

1.5

—

(3019150) Specific gravity of Urine by Refractometry

1332

14406

0.91

2.57

4.4

4.5

kg/l

1.0

0.01

219

2215

(3012441) Differential panel - Pleural fluid

128

964

1.33

2.55

1.4

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

114

2.02

2.55

1.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

315

0.44

2.51

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

3332

31951

1.07

2.49

5.6

5.3

estimate

0.0

0.33

761

5943

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

357

3044

1.18

2.40

3.6

4.1

mmol/l

24.7

24.8

0.32

319

2754

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

131

1.91

2.39

2.4

4.2

u/l

64.1

39.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

273

1.61

2.39

2.4

2.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

632

1.40

2.39

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

632

1.40

2.39

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

632

1.40

2.39

1.4

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

177

2211

0.80

2.37

2.7

2.3

g/l

0.0

0.63

151

1982

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.06

2.36

1.1

1.2

ng/l

103.9

970.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

418

1.49

2.35

1.5

u/l

8.2

6.2

0.30

187

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

110

1456

0.75

2.33

1.6

1.7

nmol/l

41.6

44.6

0.80

104

1384

(3044290) Cell count panel - Cerebral spinal fluid

1135

0.72

2.33

1.2

1.3

—

(3014271) Vancomycin [Susceptibility]

502

1.44

2.31

3.0

2.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.22

2.30

1.0

1.2

nmol/l

195.6

282.8

—

(3035350) Ketones [Presence] in Urine by Test strip

3321

31917

1.07

2.27

4.2

4.0

estimate

0.0

0.50

746

5893

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

570

0.61

2.25

1.1

—

2.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

259

0.42

2.25

1.1

—

(3022313) Gas panel - Capillary blood

411

3570

1.16

2.21

3.4

3.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

194

2378

0.81

2.21

2.7

2.3

g/l

0.2

0.1

0.31

168

2142

(40768443) Skin Pathology biopsy report

262

3117

0.84

2.19

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

272

1.58

2.19

1.2

1.3

ug/l

1134.6

321.4

0.74

142

(1001926) Buprenorphine [Presence] in Urine by Screen method

427

0.56

2.17

1.1

1.6

—

(4027681)

255

0.43

2.17

1.4

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

687

1.36

2.16

1.6

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

887

0.70

2.16

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

791

0.68

2.14

1.1

1.2

miu/ml

178.8

185.5

0.03

253

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

370

1.49

2.14

1.7

1.6

u/l

133.7

1359.6

0.93

125

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

227

2725

0.83

2.11

2.5

2.4

g/l

0.8

1.0

0.33

183

2284

(3024928) Oxygen saturation in Venous blood

192

1574

1.23

2.01

1.7

2.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

731

1.33

2.00

1.6

1.7

—

(3042733) HLA Ab [Presence] in Serum

148

0.34

1.99

2.2

4.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

258

0.46

1.97

1.0

1.1

u/l

4.1

1.1

—

129

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

463

0.60

1.96

1.0

—

(3027008) Opiates [Presence] in Urine

561

0.64

1.95

1.1

1.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

243

0.45

1.95

1.3

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

318

2739

1.17

1.95

2.0

2.3

ug/l

389.5

660.1

1.62

310

2588

(3028707) Methadone [Presence] in Urine by Screen method

270

0.48

1.95

1.0

1.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

266

1.54

1.91

1.9

3.7

58.4

54.5

0.56

254

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

255

2997

0.85

1.90

2.3

g/l

10.1

10.3

0.24

198

2473

(3039443) Prostate specific Ag panel - Serum or Plasma

1162

0.75

1.90

1.6

1.7

—

(3037756) Immunofixation for Serum or Plasma

149

1843

0.80

1.89

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.00

1.89

2.7

2.8

u/field

0.8

0.3

0.92

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

173

0.40

1.89

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

358

0.56

1.89

1.1

2.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

299

1.51

1.89

1.1

4.0

mg/l

55.9

66.2

0.69

211

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1216

0.76

1.87

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

209

2495

0.83

1.87

2.5

2.2

g/l

36.9

37.2

0.30

158

2088

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2286

23925

0.94

1.86

4.3

4.7

21.7

22.2

0.85

1173

12713

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

542

0.64

1.86

1.1

—

46.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

110

854

1.29

1.86

1.2

1.3

u/l

293.0

401.7

0.99

102

808

(3028300) Cannabinoids [Presence] in Urine

565

0.65

1.85

1.1

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

511

5701

0.89

1.83

2.4

—

(3020491) Glucose [Moles/volume] in Blood

490

0.63

1.82

1.8

2.1

mmol/l

8.3

7.1

0.88

330

(3038177) Helicobacter pylori Ab [Presence] in Serum

100

770

1.30

1.81

1.3

—

(3016879) Cocaine [Presence] in Urine

525

0.65

1.80

1.1

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

184

0.43

1.79

1.0

1.2

—

24.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

155

1262

1.23

1.78

1.3

1.5

g/l

30.8

31.5

0.29

140

1115

(3006442) Creatine [Moles/volume] in Serum or Plasma

428

1.40

1.77

1.3

1.7

umol/l

86.8

70.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1694

16038

1.07

1.76

1.7

pmol/l

6214312.5

29694345.4

2.65

1384

12905

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.93

1.74

1.4

1.2

ug/l

44.4

117.2

4.06

(3003327) Ova and parasites identified in Stool by Light microscopy

192

1602

1.20

1.73

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

170

1.65

1.73

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

147

1799

0.81

1.72

1.6

e6/l

16036.5

16013.3

0.00

109

1279

(3000764) Benzodiazepines [Presence] in Urine

555

0.67

1.72

1.1

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

334

0.57

1.71

1.3

1.1

—

(36660697) Celiac disease serology panel - Serum

457

4085

1.13

1.68

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

136

1100

1.24

1.67

1.4

1.5

e6/l

1032.6

2368.6

4.12

103

792

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

409

1.40

1.65

2.4

2.3

—

(3027944) Amphetamines [Presence] in Urine

549

0.67

1.64

1.1

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1236

0.78

1.64

1.2

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

695

1.30

1.62

1.9

—

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

242

2075

1.17

1.62

2.9

3.1

mmol/l

24.1

25.0

2.05

213

1803

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

352

1.42

1.61

1.1

u/l

82.2

89.1

0.29

265

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

132

0.38

1.61

1.0

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

414

4636

0.89

1.61

2.6

2.7

g/l

9.9

10.6

2.02

372

4218

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

230

1.52

1.59

1.3

1.4

25.3

23.9

0.10

189

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

122

1507

0.81

1.59

1.2

u/ml

50.0

44.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

1000

1.24

1.58

1.4

1.5

e6/l

128914.5

63967.9

0.52

589

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

256

2955

0.86

1.57

1.1

1.2

iu/ml

140.2

124.9

0.24

1026

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

355

1.41

1.55

1.3

1.5

56.0

67.0

1.17

288

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

709

1.29

1.55

1.1

1.2

u/l

96.2

63.9

0.70

456

(3020630) Protein [Mass/volume] in Serum or Plasma

622

6796

0.91

1.54

2.5

g/l

65.0

66.1

2.45

549

6062

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

3203

0.87

1.53

2.3

g/l

3.7

3.8

0.46

183

2238

(3001893) Eosinophils/100 leukocytes in Pleural fluid

298

1.45

1.52

1.4

1.5

3.9

2.5

0.29

248

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.83

1.51

2.0

2.1

ug/l

3.1

8.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

281

3210

0.87

1.51

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

394

0.63

1.50

1.2

2.2

e6/l

520.3

496.6

0.10

329

(3000012) Reticulocyte production index

469

1.35

1.49

1.3

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

170

1.59

1.48

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

429

0.65

1.48

2.2

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

282

3214

0.87

1.47

2.3

g/l

7.6

7.4

1.03

198

2326

(4146454)

107

858

1.25

1.46

2.9

2.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

367

0.63

1.46

1.3

1.4

pmol/l

107.6

136.7

—

118

(3017354) Segmented neutrophils/100 leukocytes in Blood

100

796

1.26

1.45

2.5

3.6

60.8

57.9

0.52

500

(3022475) Manganese [Moles/volume] in Blood

2.50

1.45

1.7

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

354

0.62

1.45

2.2

2.6

39.4

36.6

—

129

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1136

0.79

1.44

1.4

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

352

1.39

1.44

1.1

u/l

31.7

0.00

258

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

215

0.51

1.44

1.0

1.1

u/ml

—

8.3

—

(3045414) Leukocytes [Presence] in Urine

336

2980

1.13

1.44

2.2

2.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

266

0.56

1.43

1.2

g/l

40.4

40.1

—

130

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

648

0.72

1.42

1.3

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

116

1418

0.82

1.40

1.2

u/ml

2.3

6.3

2.56

223

(3017569) Oxygen content in Arterial blood

423

1.35

1.39

2.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

855

1.24

1.39

1.3

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

287

0.59

1.37

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

550

0.71

1.36

1.1

u/ml

1.2

1.6

0.34

216

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

115

1402

0.82

1.36

1.2

u/ml

9.3

5.3

0.39

142

(3047189) Immunofixation for 24 hour Urine

408

0.66

1.36

1.4

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

902

0.77

1.35

1.9

1.8

mu/l

260.7

308.2

0.96

836

(3051101) Glucose [Moles/volume] in Cord blood

165

0.48

1.34

3.3

6.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

349

1.38

1.34

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

358

0.64

1.33

1.6

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

418

1.34

1.33

2.1

1.9

—

(44813793)

309

0.61

1.33

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

1.32

0.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.32

0.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

417

0.67

1.32

1.1

—

(3024932) HLA-DR beta [Type]

146

0.48

1.31

1.3

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

325

1.39

1.31

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

325

1.39

1.31

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

116

1406

0.82

1.31

1.6

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

1.31

0.0

1.0

—

(3024263) Appearance of Synovial fluid

404

0.67

1.30

1.7

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

233

2033

1.15

1.30

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.50

1.30

6.3

5.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.50

1.30

3.2

2.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

657

1.27

1.30

1.3

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.35

1.29

4.1

2.5

—

(3016018) Differential panel - Cerebral spinal fluid

589

0.73

1.28

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

378

1.35

1.28

2.8

3.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

459

0.70

1.25

1.0

1.1

u/ml

1.1

1.0

0.11

184

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

172

1473

1.17

1.24

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

117

969

1.21

1.23

1.4

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

215

0.56

1.22

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

421

0.69

1.22

1.4

2.3

e6/l

413.3

561.9

—

175

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

1.44

1.22

3.7

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

1.44

1.22

3.7

2.2

—

(3049717) Cytology report of Urine Cyto stain

386

3497

1.11

1.20

2.9

2.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

567

1.27

1.19

1.0

1.1

u/ml

6.7

3.1

0.38

184

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

230

1.44

1.19

2.4

2.5

—

33.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

290

3245

0.89

1.19

3.0

3.2

pmol/l

4.3

4.4

1.15

258

2803

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

144

1221

1.18

3.1

3.3

—

(3035880) pH of Pleural fluid

506

1.29

1.18

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

104

1258

0.82

1.18

1.7

iu/l

7.7

4.5

0.79

384

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

1275

0.83

1.14

1.2

1.3

u/l

40.9

39.8

0.04

1102

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.14

0.0

11.5

—

225.7

—

(3024471) HLA-A [Type]

152

0.53

1.13

1.0

—

(3022689) Creatine [Moles/volume] in Urine

197

0.56

1.13

1.5

1.4

—

(3021788) Differential panel - Synovial fluid

110

1317

0.83

1.13

1.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

125

1478

0.84

1.12

1.5

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.12

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

471

0.72

1.12

1.0

1.1

u/ml

1.5

3.1

1.05

210

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

377

0.69

1.11

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

686

0.77

1.10

1.5

29.9

28.5

0.10

436

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

376

0.69

1.09

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

376

0.69

1.09

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

138

0.51

1.09

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.73

1.08

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

140

0.50

1.08

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

247

2197

1.13

1.08

4.8

4.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

131

1113

1.18

1.08

2.7

2.4

—

(3011412) CD3 cells [#/volume] in Blood

593

0.76

1.08

1.6

2.2

e9/l

1.3

1.1

0.31

364

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

146

1696

0.86

1.07

1.3

1.4

g/l

0.2

0.66

138

1599

(3009445) Proteinase 3 Ab [Units/volume] in Serum

275

3062

0.89

1.06

1.5

u/ml

29.4

19.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

373

0.70

1.06

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

373

0.70

1.06

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

241

2703

0.89

1.05

2.7

3.1

ratio

1.4

3.3

1.72

211

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

296

1.35

1.05

1.1

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

179

0.56

1.04

1.0

1.1

miu/ml

1571.5

1656.1

—

179

(40759836) Histone Ab [Presence] in Serum by Immunoblot

372

0.70

1.04

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

331

3644

0.90

1.04

2.1

1.8

g/l

1.5

1.4

0.23

299

3259

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

124

1053

1.18

1.03

1.3

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

228

0.61

1.03

1.4

1.2

g/l

—

0.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

114

1.58

1.02

1.2

u/l

36.0

339.5

0.56

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

2980

0.90

1.02

2.4

2.3

g/l

3.2

3.1

0.50

190

2281

(3003181) Sodium [Moles/volume] in Urine

161

1399

1.15

1.01

1.4

1.3

mmol/l

58.4

62.4

0.55

112

1123

(3000034) Microalbumin [Mass/volume] in Urine

699

1.22

1.00

3.4

3.0

mg/l

61.1

42.5

0.26

525

(3028679) Herpes simplex virus Ab [Presence] in Serum

214

0.61

1.00

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

180

1.45

1.00

1.5

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

730

0.79

0.99

1.6

1.3

e6/l

54216.9

175797.4

2.23

486

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

150

1727

0.87

0.99

1.4

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

851

0.81

0.99

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

132

0.53

0.98

1.1

1.0

—

(40768800) Prostate Pathology biopsy report

173

1970

0.88

0.98

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

213

1893

1.13

0.97

3.3

3.4

mmol/l

1.7

0.41

208

1847

(3037692) Legionella sp identified in Specimen by Organism specific culture

272

0.66

0.97

1.1

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

103

1219

0.84

0.97

1.2

—

18.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

250

2779

0.90

0.96

2.7

3.2

mg/l

62.2

81.2

0.41

211

2257

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

342

0.70

0.96

1.4

1.5

nmol/l

0.4

0.2

0.30

253

(3017817) Protein [Mass] in Urine collected for unspecified duration

685

1.21

0.96

2.2

—

0.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

250

2777

0.90

0.95

2.7

3.2

mg/l

40.1

51.6

1.11

210

2254

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

198

0.61

0.95

1.0

1.1

81.4

93.7

—

146

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.65

0.94

1.5

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

214

1908

1.12

0.94

3.1

nmol/l

0.8

0.02

161

1462

(3032773) Endomysium IgG Ab [Titer] in Serum

426

1.27

0.93

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

363

0.72

0.93

1.1

nmol/l

0.6

11.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

179

2025

0.88

0.93

1.4

—

(3003129) Base excess in Capillary blood by calculation

221

0.63

0.93

1.3

1.8

mmol/l

-0.1

0.7

0.80

204

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

184

0.60

0.92

1.2

2.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

154

1754

0.88

0.90

1.3

1.5

g/l

1.2

0.10

145

1654

(3023410) Appearance of Cerebral spinal fluid

518

0.77

0.88

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1119

0.85

0.87

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

233

2581

0.90

0.86

1.8

1.7

u/l

38.5

38.2

0.09

207

2192

(3002619) Bacteria identified in Specimen by Culture

136

1.47

0.86

1.5

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.72

0.86

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

127

1103

1.15

0.85

1.7

1.8

ug/l

19.4

23.3

0.92

122

1078

(3044941) Cell count panel - Synovial fluid

1137

0.85

0.84

1.4

—

(3006462) Nitrate [Presence] in Urine

326

1.29

0.84

4.8

3.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

115

1328

0.86

0.83

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

137

0.58

0.83

1.5

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

238

0.67

0.82

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

512

0.78

0.82

1.3

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

142

1614

0.88

0.82

1.8

mg/l

11.4

12.2

0.45

132

1477

(40760888) Immunoglobulin light chains.free panel - Serum

188

2099

0.89

0.82

2.6

3.3

—

(3006270) Folate [Moles/volume] in Blood

653

1.20

0.81

1.2

nmol/l

324.7

332.3

0.11

505

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.64

0.81

1.6

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

664

1.19

0.79

1.2

1.3

u/l

10.6

13.6

1.60

603

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.79

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

147

0.61

0.78

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.77

0.0

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

530

1.21

0.76

1.1

1.2

95.7

94.8

0.10

488

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.76

0.0

7.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

268

0.71

0.76

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

113

984

1.15

0.75

1.8

2.2

mg/l

33.1

26.1

0.31

243

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

302

0.73

0.75

1.1

—

(3045788) Cell count panel - Pleural fluid

854

1.16

0.75

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

158

1.39

0.74

1.1

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

135

0.59

0.73

1.3

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

135

0.59

0.73

5.1

7.4

—

(4211845)

361

1.25

0.72

4.6

3.5

—

(4015189)

241

0.70

0.71

1.8

2.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

831

1.16

0.70

1.2

1.4

mmol/l

6.6

6.4

0.36

755

(3006245) CD3-CD19+ cells/100 cells in Blood

194

0.67

0.70

1.2

1.9

23.3

10.7

1.05

169

(40758358) Immune stain study

1.92

0.70

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

123

1085

1.14

0.70

1.2

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

139

1237

1.13

0.69

3.1

5.0

iu/ml

391.9

2610.7

0.92

186

(46235355) HIV 1 and 2 tests - Meaningful Use set

577

6087

0.94

0.68

1.3

1.5

—

(3000285) Sodium [Moles/volume] in Blood

117

0.60

0.67

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

835

1.15

0.67

3.0

4.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.63

0.66

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

462

0.80

0.66

5.4

5.1

u/ml

38.2

74.7

—

138

(3029396) Erythrocyte agglutination [Presence] in Blood

1.79

0.66

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

531

1.19

0.65

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

138

1234

1.12

0.64

1.4

1.5

nmol/l

0.8

0.26

116

1006

(3008116) Ketones [Moles/volume] in Urine by Test strip

137

1.39

0.64

1.1

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

449

0.80

0.64

1.6

2.0

15.1

15.5

0.04

173

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

771

7378

1.05

0.64

2.2

2.5

ug/l

5.1

7.0

2.91

651

6300

(21494890) Protein electrophoresis panel - 24 hour Urine

882

0.86

0.64

2.1

2.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

558

0.82

0.63

1.3

titre

116.0

298.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

287

1.26

0.63

5.7

6.6

mmol/l

25.3

24.8

0.36

256

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2497

24452

1.03

0.62

4.6

4.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

153

0.65

0.62

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

933

0.87

0.62

1.1

1.2

—

(3004451) EKG impression Narrative

433

1.20

0.62

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

932

0.87

0.61

1.2

1.4

iu/l

39.4

33.0

0.87

789

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

760

0.85

0.61

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

471

1.19

0.60

1.4

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

471

1.19

0.60

1.4

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.48

0.60

1.1

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.60

0.0

1.2

—

3.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

891

9255

0.96

0.59

11.7

8.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.44

0.58

2.0

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

628

0.84

0.58

1.1

1.2

mmol/l

7.6

7.9

0.27

445

(3017509) Phencyclidine [Presence] in Urine

0.00

0.58

0.0

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

649

0.85

0.58

1.7

1.6

u/ml

28.9

25.8

—

142

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

116

0.60

0.57

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

219

0.73

0.57

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

161

0.68

0.57

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

161

0.68

0.57

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

161

0.68

0.57

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

161

0.68

0.57

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

265

1.25

0.56

1.3

1.5

28.2

18.1

1.17

240

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

195

0.72

0.56

1.2

1.9

22.9

29.9

1.14

176

(3034891) Synovial lining cells/100 cells in Synovial fluid

341

0.79

0.55

1.4

1.5

2.1

3.9

—

(3011648) Oxygen content in Venous blood

541

1.17

0.55

1.3

1.8

11.0

10.9

0.11

541

(40757373) Influenza virus identified in Isolate

160

0.69

0.55

1.3

1.4

—

(3014891) Appearance of Pleural fluid

133

1.35

0.54

1.9

1.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

126

0.63

0.54

1.0

1.2

—

580.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3002

30503

0.97

0.53

2.2

2.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

244

2271

1.08

0.53

1.1

titre

108.0

184.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.45

0.53

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

918

0.88

0.52

1.6

1.5

65.7

62.2

0.35

592

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

180

1954

0.92

0.52

2.3

ug/min

152.1

110.5

0.42

102

1123

(40761535) Cells panel - Urine sediment

605

6315

0.95

0.52

3.5

3.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

103

921

1.12

0.52

8.9

14.7

mmol/l

6.7

7.5

2.85

746

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

133

0.68

0.51

2.3

2.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

842

0.88

0.51

1.1

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

538

1.15

0.49

1.4

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

543

5671

0.95

0.49

3.4

3.8

ng/l

100.4

97.4

0.30

468

4743

(3009214) Lutropin [Units/volume] in Serum or Plasma

997

0.89

0.49

1.3

u/l

18.1

10.4

3.25

796

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

107

1186

0.90

0.49

1.1

1.2

u/ml

5.3

5.1

—

(3017732) Neutrophils [#/volume] in Blood

450

4287

1.05

0.48

4.0

3.2

e9/l

3.9

4.2

1.38

336

3077

(1617658) Protocol used for examination of sentinel lymph nodes

421

0.83

0.48

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

154

1.30

0.48

1.4

1.5

14.3

8.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

110

0.64

0.48

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

593

0.86

0.48

1.2

1.4

—

(3008295) Osmolality of Serum or Plasma

742

0.87

0.48

1.2

1.3

mosm/kgh2o

273.2

278.2

1.38

562

(3024980) IgG subclass 4 [Mass/volume] in Serum

911

0.89

0.48

1.5

1.6

g/l

1.0

0.9

0.20

689

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

568

1.15

0.48

1.2

1.6

—

(44790049)

766

1.12

0.47

1.2

1.4

—

(44790048)

766

1.12

0.47

1.2

1.4

—

(44806118)

766

1.12

0.47

1.2

1.4

—

(44790047)

766

1.12

0.47

1.2

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2313

23546

0.98

0.47

4.2

4.0

mg/mmol

11.2

9.4

0.95

1521

14907

(3036071) Salmonella sp Ab [Titer] in Serum

143

0.70

0.47

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

541

5644

0.96

0.47

1.3

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

115

1043

1.10

0.47

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

438

0.84

0.44

1.8

2.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.37

0.44

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

2221

22597

0.98

0.44

3.3

3.2

mmol/l

7.4

7.3

0.39

1818

18545

(3051387) C reactive protein [Mass/volume] in Capillary blood

145

1572

0.92

0.43

3.7

3.8

mg/l

33.0

29.5

0.45

1027

(4133840)

139

1.30

0.43

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

230

0.78

0.43

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

128

0.70

0.43

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

115

1049

1.10

0.43

1.3

1.4

—

(4062490)

575

0.87

0.42

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.43

0.42

1.3

1.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

131

1.30

0.42

1.1

1.8

ug/l

2.6

2.3

—

(4198724)

0.63

0.42

1.0

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

327

0.83

0.41

1.3

1.8

—

7.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.52

0.41

1.6

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.52

0.41

2.4

2.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.52

0.41

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.2

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.41

0.0

7.5

—

71.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.41

0.0

4.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

434.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

636

0.88

0.40

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

983

0.90

0.40

3.1

2.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

128

1179

1.09

0.40

1.3

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

238

0.80

0.40

1.5

1.9

umol/l

117.8

129.8

—

135

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.40

0.0

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.36

0.40

2.0

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.36

0.40

2.0

2.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

278

1.19

0.39

1.5

2.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.31

0.39

1.1

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

897

0.90

0.39

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

0.67

0.39

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

1.7

—

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

335

0.84

0.39

1.0

1.1

u/ml

4.1

2.3

—

131

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

428

1.15

0.38

2.1

ug/min

48.7

179.9

1.48

107

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

750

1.11

0.38

1.2

u/ml

5.1

3.6

0.33

229

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

313

0.83

0.38

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

178

1.24

0.38

2.2

2.4

mmol/l

7.7

7.9

0.08

112

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1052

0.91

0.38

1.1

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

622

0.88

0.38

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.36

0.38

10.6

13.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.39

0.38

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

853

0.90

0.38

1.1

1.2

u/ml

298.8

290.1

0.08

524

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.30

0.37

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

667

1.11

0.37

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

734

1.10

0.36

1.2

u/ml

2.4

4.4

2.47

314

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

223

2359

0.94

0.36

1.6

titre

153.3

238.2

—

109

(3012516) Albumin [Mass/volume] in Urine

2194

22269

0.98

0.36

3.3

3.2

mg/l

248.4

359.9

0.83

1489

14236

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

342

0.85

0.35

6.0

6.3

—

(3046861) Legionella sp Ag [Presence] in Urine

1.43

0.35

1.3

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

395

0.86

0.35

1.0

1.1

u/ml

2.4

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

311

1.16

0.34

1.3

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

468

0.88

0.34

1.1

1.2

titre

90.0

151.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.33

0.33

2.5

3.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

908

0.91

0.33

1.2

1.4

u/ml

99.5

120.4

1.28

195

(3024139) IgG subclass 3 [Mass/volume] in Serum

573

0.89

0.33

1.3

g/l

0.4

0.78

403

(3028192) IgG subclass 2 [Mass/volume] in Serum

573

0.89

0.33

1.3

g/l

2.7

2.9

0.34

405

(3027135) IgG subclass 1 [Mass/volume] in Serum

573

0.89

0.33

1.3

g/l

6.4

7.0

0.54

400

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.30

0.33

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

551

0.89

0.33

1.9

ug/l

3.9

3.5

0.26

479

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

209

0.81

0.32

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

165

0.79

0.32

6.0

8.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.30

0.31

1.2

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.30

0.31

1.2

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.30

0.31

1.2

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.30

0.31

1.2

1.3

—

(3045716) Anion gap in Serum or Plasma

370

1.14

0.31

2.9

2.1

mmol/l

9.4

9.3

0.08

292

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

433

0.88

0.31

3.6

3.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.32

0.30

2.3

5.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

193

1.19

0.30

1.3

29.9

33.6

0.20

125

(4268621)

485

1.11

0.30

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

221

1.18

0.30

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.33

0.30

1.2

1.3

—

(3005033) Fetal Nuchal fold Thickness US

1.33

0.30

1.2

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

467

1.11

0.29

2.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2678

26481

1.02

0.29

2.2

nmol/l

76.3

79.1

5.41

2367

23076

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

0.80

0.29

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

315

3277

0.96

0.29

1.2

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

765

1.09

0.29

1.3

nmol/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

139

1.22

0.29

1.4

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

891

1.08

0.28

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

223

1.17

0.28

1.8

1.3

umol/l

13.5

15.3

0.10

145

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

216

0.83

0.28

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.28

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

172

0.81

0.27

1.1

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

121

0.74

0.27

1.1

1.3

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.69

0.26

5.4

9.1

umol/l

0.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

405

1.11

0.26

1.3

1.2

mmol/l

11.1

11.9

0.35

132

(3025130) Human papilloma virus identified in Specimen

358

1.12

0.25

1.5

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.22

0.25

7.0

5.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.22

0.25

2.1

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.22

0.25

2.1

2.3

—

(3000330) Specific gravity of Urine by Test strip

401

3891

1.03

0.24

5.3

3.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.26

0.24

2.2

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

411

0.90

0.23

1.3

1.1

—

(3025577) Chromium [Mass/volume] in Blood

536

0.91

0.23

2.0

ug/l

2.0

2.1

0.18

444

(3042010) Triglyceride [Moles/volume] in Pleural fluid

134

1.19

0.22

1.3

1.2

mmol/l

0.9

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.77

0.22

1.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.27

0.22

1.3

1.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

2.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1396.4

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.2

—

97.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

262

0.88

0.21

1.8

2.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

101

0.79

0.21

12.6

13.4

mmol/l

7.4

5.2

—

101

(3022621) pH of Urine by Test strip

467

4557

1.03

0.21

3.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

325

1.11

0.21

1.4

1.3

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

799

1.06

0.20

1.2

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.22

0.20

1.0

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

231

1.13

0.19

4.8

5.4

65.5

71.7

0.54

184

(3042631) Mycobacterium sp identified in Specimen

125

1192

1.05

0.19

2.0

2.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.22

0.19

1.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

164

1575

1.04

0.19

2.6

2.3

—

(3017704) Immunofixation for Urine

478

0.92

0.19

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

395

1.09

0.18

2.5

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

357

1.09

0.18

1.2

1.3

nmol/l

1.4

1.2

0.55

269

(21494434) Karyotype in Bone marrow

703

0.94

0.18

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.22

0.17

1.9

1.6

umol/l

47.4

42.8

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.22

0.17

2.8

2.5

pmol/l

51.3

73.4

—

(4024509)

718

1.06

0.17

1.7

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.76

0.17

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.74

0.17

2.2

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.74

0.17

1.4

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.72

0.16

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

297

2893

1.03

0.16

2.3

2.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

495

0.93

0.16

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

398

1.08

0.16

1.1

1.2

u/l

125.7

92.1

0.72

337

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

246

0.89

0.16

2.9

2.1

umol/l

53.1

59.0

0.49

191

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2971

29894

0.99

0.16

4.9

5.4

ug/l

3.3

4.0

0.81

2583

26520

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.20

0.16

1.3

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

322

1.09

0.15

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

872

0.95

0.15

1.2

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

114

1188

0.96

0.15

1.1

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.14

0.15

6.6

4.8

ug/min

59.1

49.5

—

(3044927) Protein electrophoresis panel - Urine

878

1.05

0.15

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

1320

1.04

0.15

1.2

1.4

—

(3020650) Glucose [Presence] in Urine

140

1.14

0.15

1.4

1.5

—

(40758292) HTLV I+II Ab panel - Serum

0.81

0.14

1.3

1.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.79

0.14

1.3

1.7

pmol/l

12.9

45.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

326

0.92

0.14

1.1

—

(3036603) Volume of Urine

460

1.07

0.14

1.7

1802.7

1853.0

0.10

125

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

208

1.11

0.14

1.3

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

103

1.17

0.13

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

189

1.11

0.13

2.0

1.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

284

0.92

0.13

1.1

1.3

mmol/l

6.2

0.06

265

(3035933) Granulocytes/100 leukocytes in Blood

108

0.83

0.13

1.3

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

109

1050

1.04

0.13

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

558

5498

1.02

0.13

1.5

1.7

1.6

0.09

473

4588

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

874

1.04

0.12

1.3

nmol/l

0.6

0.7

0.48

836

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

185

1802

1.03

0.12

1.4

1.5

—

(3015736) pH of Urine

2529

25155

1.01

0.11

3.8

5.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

670

1.05

0.11

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

178

0.90

0.11

1.1

1.4

—

1541616.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

474

1.06

0.11

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

474

1.06

0.11

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

690

1.04

0.11

1.1

111.0

114.7

0.51

602

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

157

0.89

0.11

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

740

1.04

0.10

1.2

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

870

8784

0.99

0.10

4.3

4.9

33.0

33.1

0.10

557

5733

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

189

1934

0.98

0.10

1.3

1.4

iu/ml

18.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

387

1.06

0.10

1.1

1.2

u/l

52.1

25.3

0.82

322

(3023430) Cat dander IgE Ab [Units/volume] in Serum

311

0.93

0.10

1.0

1.1

u/ml

3.2

2.8

—

119

(3011397) Hemoglobin [Presence] in Urine by Test strip

1575

15645

1.01

0.10

3.6

4.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

790

1.04

0.10

1.1

1.3

pmol/l

258.0

270.8

0.19

600

(3000093) Morphology [Interpretation] in Blood Narrative

779

0.96

0.10

1.1

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

849

0.97

0.09

1.2

1.1

iu/ml

9661.4

1207.6

0.41

171

(3034426) Prothrombin time (PT)

174

1.09

0.09

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

458

1.05

0.09

1.1

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.11

0.09

1.5

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

136

1.10

0.08

1.1

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

107

1.12

0.08

1.1

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.83

0.08

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.82

0.08

1.0

1.1

u/l

8.2

11.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

491

0.96

0.08

1.1

1.2

—

(44806071)

0.79

0.08

1.0

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

556

5504

1.01

0.08

2.3

nmol/l

402.5

377.0

2.08

517

5005

(3027035) Albumin [Mass/time] in 24 hour Urine

0.77

0.08

1.4

1.3

—

555.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.06

0.08

1.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

205

1.07

0.07

1.3

1.7

—

(3004775) Volume in Urine collected for unspecified duration

638

1.03

0.07

2.0

2.2

747.0

639.1

0.93

399

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

174

0.92

0.07

2.0

2.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.05

0.07

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.07

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

218

2146

1.02

0.07

1.1

u/ml

2.4

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.84

0.07

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

428

0.96

0.07

1.1

1.3

promille

1.2

0.13

333

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.83

0.07

1.4

1.2

—

(3003338) MCHC [Mass/volume]

4964

49725

1.00

0.07

40.4

22.4

g/l

329.2

331.7

61.87

4922

49201

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

163

0.92

0.07

1.1

—

(40768446) Kidney Pathology biopsy report

214

0.93

0.07

1.5

1.6

—

(4306422)

709

1.03

0.07

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

244

0.94

0.06

2.0

1.8

ug/l

68.3

53.6

0.76

234

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

617

0.97

0.05

1.3

1.2

nmol/l

1.2

1.5

1.39

546

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

141

0.92

0.05

1.0

1.1

86.4

81.0

—

(3051593) INR in Capillary blood by Coagulation assay

445

0.97

0.05

8.6

12.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

287

1.05

0.05

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

171

0.94

0.05

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

844

1.02

0.04

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

725

0.98

0.04

1.1

—

(3048879) Bone marrow aspiration report

251

0.96

0.04

1.2

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

170

1.06

0.04

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

368

1.03

0.04

1.4

1.3

u/l

39.5

32.9

0.48

297

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

1.07

0.03

1.0

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

399

4012

0.99

0.03

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

280

0.96

0.03

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

179

0.95

0.03

1.1

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

102

1.08

0.03

1.1

—

(3011985) Renin [Units/volume] in Plasma

848

1.01

0.02

1.2

1.4

mu/l

68.7

57.1

0.21

748

(40768793) Breast Pathology biopsy report

118

1167

1.01

0.02

1.4

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

460

1.02

0.02

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

791

0.99

0.02

4.1

3.6

—

(44806420)

278

0.97

0.02

2.6

2.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

173

1.04

0.01

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

183

1.04

0.01

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

307

0.98

0.01

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.06

0.01

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

156

0.96

0.00

1.5

ug/l

10.6

9.6

0.45

156

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

144

0.97

0.00

1.0

1.3

90.8

79.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

354

0.99

0.00

1.2

1.3

u/ml

0.1

1.6

2.37

185

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

196

1.02

0.00

6.0

7.9

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

172

0.99

0.00

1.3

1.2

mmol/l

1.5

1.6

—

106

(3028433) Virus identified in Specimen by Culture

232

0.99

0.00

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

232

0.99

0.00

1.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

312

0.99

0.00

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

852

1.00

0.00

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

108

1080

1.00

0.00

1.2

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

139

1.01

0.00

1.2

umol/24h

0.7

—

(3024869) Neuronal Ab [Presence] in Serum

149

1.01

0.00

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

153

0.98

0.00

1.1

1.2

pmol/l

298.7

274.8

0.11

108

(3001186) Copper [Moles/volume] in Serum or Plasma

123

0.98

0.00

1.2

1.1

umol/l

18.1

16.1

1.68

112

(3016750) Collection duration of Urine

438

1.00

0.00

2.3

2.0

min

497.5

494.7

0.06

307

(40765096) Chromosome analysis panel by Banding

229

1.00

0.00

1.1

—

(3015183) Erythrocyte sedimentation rate

177

1.02

0.00

1.2

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

157

1.02

0.00

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

173

1733

1.00

0.00

2.7

mg/l

1.9

1.7

1.38

155

1545

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

165

0.97

0.00

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

135

0.96

0.00

1.5

1.6

ng/l

160.5

147.0

0.08

135

(3035637) Corticotropin [Mass/volume] in Plasma

778

1.00

0.00

1.6

1.5

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.96

0.00

2.9

4.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.91

0.00

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.8

—

0.3

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.98

0.00

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.91

0.00

1.3

1.4

—

(4212803)

0.96

0.00

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.94

0.00

1.5

1.3

umol/24h

1.4

1.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.99

0.00

1.0

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.95

0.00

3.5

2.4

—

60.5

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.00

0.00

1.5

1.3

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.91

0.00

1.1

1.6

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.02

0.00

1.7

1.8

—

(4038314)

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.3

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.00

0.00

1.5

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

18.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.00

0.00

1.5

1.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.2

—

11.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.02

0.00

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.95

0.00

1.0

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

134.8

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_COLORECTAL_ADENO – Colorectal adenocarcinoma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Colorectal adenocarcinoma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Colorectal adenocarcinoma (C3_COLORECTAL_ADENO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints